Journal Section:
Obituary
Kerstin Albertsson-Wikland
View largeDownload slide

Kerstin Albertsson-Wikland

Kerstin Albertsson-Wikland
View largeDownload slide

Kerstin Albertsson-Wikland

Close modal

The Community of Pediatric Endocrinogists mourns Senior Professor Kerstin Albertsson-Wikland who sadly passed away on October 8, 2024, at the age of 77. We, and many others in Sweden and elsewhere, remember her with gratitude for the significant contributions to research in children’s growth physiology and growth disorders. Kerstin started her research in pre-clinical medicine and became Associate Professor of Physiology at the University of Gothenburg in 1981. After her decision to pursue a clinical career, she turned her interest to pediatrics and particularly pediatric endocrinology. She was appointed full Professor in pediatric growth research 1995. Kerstin was an active researcher focusing on normal and abnormal growth of children, resulting in more than 400 peer-reviewed scientific publications. She also delivered numerous presentations in scientific meetings and organized many symposia and workshops. Her results on growth hormone (GH) secretion have made a great impact and she was asked to create national growth references for children by the Swedish National Board of Health and Welfare. Kerstin was also a driving force to set up the Swedish GH registry which has been of great importance for analyzing effects and potential adverse actions of GH. It has also been an important resource for academic studies. Kerstin supervised more than 30 PhD students, many of whom later have pursued significant independent academic careers in Sweden and elsewhere.

Kerstin's academic leadership was also recognized by the European Society for Paediatric Endocrinology (ESPE) by awarding her the highest reward, the Andrea Prader Prize, in 2017. The passing of Kerstin Albertsson-Wikland is indeed a significant loss. Her pioneering research and dedication to children's growth have left an indelible mark on the field.

Martin Ritzen, Professor emeritus

Olle Söder, Professor emeritus

Anna Olivecrona, Pediatric Endocrinologist, President, Swedish Association of Pediatrics

Stefano Cianfarani, Professor, Editor-in-Chief, Hormone Research in Paediatrics

© 2025 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2025